Imidazo (1, 2-A) pyridine derivatives useful as peptide deformylase (PDF) inhibitors

Details for Australian Patent Application No. 2006239548 (hide)

Owner Novartis AG

Inventors Thormann, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2006239548

PCT Pub. Number WO2006/114263

Priority 10 2005 019 181.9 25.04.05 DE

Filing date 24 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 29 April 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/114263 Priority application(s): WO2006/114263

29 April 2010 Application Accepted

  Published as AU-B-2006239548

26 August 2010 Standard Patent Sealed

26 August 2010 Corrigenda

  Applications Accepted - Name Index Under the name Novartis AG, Application No. 2006239548, under INID (54) correct the title to read Imidazo [1, 2-A] pyridine derivatives useful as peptide deformylase (PDF) inhibitors

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239549-Acetylene derivatives

2006239547-Acetylene derivatives